XML 111 R36.htm IDEA: XBRL DOCUMENT v3.20.1
Note 29 - Segment Information
 12 Months Ended
Dec. 31, 2019
Notes to Financial Statements  
Segment Reporting Disclosure [Text Block]
29—
SEGMENT INFORMATION
 
The Company currently has
two
reporting segments: the High Intensity Focused Ultrasound division and the Urological Devices and Services division. The following tables set forth the key Statement of Income figures, by segment for fiscal years
2019,
2018
and
2017
and the key balance sheet figures, by segment, for fiscal years
2019,
2018
and
2017.
 
The business in which the Company operates is the development and production of minimally invasive medical devices, primarily for the treatment of urological diseases. Substantially all revenues result from the sale of medical devices and their related license and royalty payments from
third
parties. The segments derive their revenues from this activity.
 
Segment operating profit or loss and segment assets are determined in accordance with the same policies as those described in the summary of significant accounting policies. Interest income and expense, current and deferred income taxes are
not
allocated to individual segments. A reconciliation of segment operating profit or loss to consolidated net loss is as follows:
 
    2019   2018   2017
Segment operating income (loss)    
2,201
      
(1,315
 )    
(2,027
 )
Financial income (expense), net    
(146
 )    
797
      
2,643
  
Foreign Currency exchange (losses) gains, net    
136
      
538
      
(909
 )
Income tax (expense) credit    
(679
 )    
(358
 )    
(388
 )
Consolidated net profit (loss)    
1,512
      
(338
 )    
(681
 )
 
A summary of the Company’s operations by segment is presented below for years ending
December 31, 2019,
2018
and
2017:
 
    HIFU Division   UDS Division  
Reconciling
items
(1)
   Total
consolidated
2019                                
Sales of goods    
8,311
      
21,800
      
-
      
30,111
  
Sales of RPPs & leases    
4,162
      
1,585
      
-
      
5,747
  
Sales of spare parts and services    
1,618
      
7,383
      
-
      
9,001
  
Total sales    
14,092
      
30,768
      
-
      
44,859
  
External other revenues    
52
      
-
      
-
      
52
  
Total revenues    
14,144
      
30,768
      
 
      
44,912
  
Total COS    
(6,152
 )    
(17,757
 )    
-
      
(23,909
 )
Gross profit    
7,991
      
13,011
      
-
      
21,002
  
R&D expenses    
(1,962
 )    
(1,766
 )    
-
      
(3,728
 )
Selling and marketing expenses    
(4,402
 )    
(6,448
 )    
-
      
(10,850
 )
G&A expenses    
(1,168
 )    
(1,758
 )    
(1,297
 )    
(4,224
 )
Total expenses    
(7,533
 )    
(9,972
 )    
(1,297
 )    
(18,802
 )
Operating income (loss) from operations    
459
      
3,039
      
(1,297
 )    
2,201
  
Total Assets    
16,665
      
32,392
      
4,012
      
53,068
  
Capital expenditures    
915
      
617
      
-
      
1,532
  
Long-lived assets    
4,096
      
6,875
      
-
      
10,971
  
Goodwill    
645
      
1,767
      
-
      
2,412
  
 
 
    HIFU Division   UDS Division  
Reconciling
Items
(1)
   Total
consolidated
2018                                
Sales of goods    
5,494
      
19,576
      
-
      
25,070
  
Sales of RPPs & leases    
3,750
      
1,336
      
-
      
5,086
  
Sales of spare parts and services    
1,780
      
7,227
      
-
      
9,007
  
Total sales    
11,025
      
28,139
      
-
      
39,163
  
External other revenues    
19
      
-
      
-
      
19
  
Total revenues    
11,044
      
28,139
      
 
      
39,183
  
Total COS    
(5,312
 )    
(16,954
 )    
-
      
(22,266
 )
Gross profit    
5,732
      
11,185
      
-
      
16,917
  
R&D expenses    
(2,394
 )    
(1,694
 )    
-
      
(4,088
 )
Selling and marketing expenses    
(4,628
 )    
(5,923
 )    
-
      
(10,551
 )
G&A expenses    
(1,036
 )    
(1,311
 )    
(1,246
 )    
(3,593
 )
Total expenses    
(8,057
 )    
(8,928
 )    
(1,246
 )    
(18,232
 )
Operating income (loss) from operations    
(2,325
 )    
2,257
      
(1,246
 )    
(1,315
 )
Total Assets    
13,648
      
29,849
      
5,243
      
48,740
  
Capital expenditures    
1,154
      
775
      
-
      
1,928
  
Long-lived assets    
2,855
      
5,158
      
-
      
8,013
  
Goodwill    
645
      
1,767
      
-
      
2,412
  
 
 
    HIFU Division   UDS Division  
Reconciling
items
(1)
   Total
consolidated
2017                                
Sales of goods    
4,232
      
18,348
      
-
      
22,580
  
Sales of RPPs & leases    
3,800
      
1,295
      
-
      
5,095
  
Sales of spare parts and services    
1,445
      
6,566
      
-
      
8,011
  
Total sales    
9,477
      
26,209
      
-
      
35,686
  
External other revenues    
36
      
24
      
-
      
60
  
Total revenues    
9,513
      
26,233
      
 
      
35,746
  
Total COS    
(4,732
 )    
(16,207
 )    
-
      
(20,938
 )
Gross profit    
4,782
      
10,026
      
-
      
14,808
  
R&D expenses    
(2,469
 )    
(1,413
 )    
-
      
(3,881
 )
Selling and marketing expenses    
(4,004
 )    
(5,521
 )    
-
      
(9,526
 )
G&A expenses    
(1,009
 )    
(1,057
 )    
(1,362
 )    
(3,428
 )
Total expenses    
(7,482
 )    
(7,991
 )    
(1,362
 )    
(16,835
 )
Operating income (loss) from operations    
(2,701
 )    
2,035
      
(1,362
 )    
(2,027
 )
Total Assets    
11,333
      
27,803
      
7,761
      
46,897
  
Capital expenditures    
1,190
      
928
      
-
      
2,118
  
Long-lived assets    
2,804
      
4,278
      
-
      
7,082
  
Goodwill    
645
      
1,767
      
-
      
2,412
  
 
(
1
)
For year
2017,
these data were reported under “EDAP TMS (Corporate)”